Sympathoadrenal activity, catecholamines, and the pathogenesis of vasculopathic hypertensive target-organ damage

American Journal of Hypertension

Volumn 2, Issue 12, 1989, Pages 305S-312S

  Izzo, Joseph L ^a  

^a NONE

Author keywords

Arterial pressure; Baroreflexes; Cardiovascular system; Hemodynamic effects; Norepinephrine; Sympathoadrenal system

Indexed keywords

ANTIHYPERTENSIVE AGENT; CATECHOLAMINE;

ADRENAL MEDULLA; ADRENERGIC SYSTEM; ADULT; CARDIOVASCULAR SYSTEM; CONFERENCE PAPER; HUMAN; HYPERTENSION; HYPERTENSIVE VASCULOPATHY; INJURY;

ADRENAL GLANDS; ANIMAL; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD VESSELS; BODY WATER; CATECHOLAMINES; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY; MICROCIRCULATION; PRESSORECEPTORS; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 0024834179     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/2.12.305S     Document Type: Article

References (52)

1. Goldstein DS, McCarty R, Polinsky RJ, et al: Relationship between plasma norepinephrine and sympathetic neural activity. Hypertension 1983;5:552-559.
2. Cryer PE: Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med 1980;303(8):436-444.
3. Goldstein DS, Zimlichman R, Stull R, et al: Measurement of regional neuronal removal or norepinephrine in man. J Clin Invest 1985;76:15-21.
4. Esler M: Assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics. Clin Sci 1982;62:247-254.
5. Izzo JL, Jr, Stems RH: Abnormal norepinephrine release in uremia. Kidney Int 1983;24:S221-S223.
6. Wallin BG, Sundlof G: A quantitative study of muscle nerve sympathetic activity in resting normotensive and hypertensive subjects. Circ Res 1973;33:9-21.
7. Wallin BG, Sundlof G, Eriksson BM, et al: Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. Acta Physiol Scand 1981;111:69-73.
8. Izzo JL, Jr: The sympathoadrenal system in the maintenance of elevated arterial pressure. J Cardiovasc Pharmacol 1984;6:S514-S521.
9. Vestal RE, Wood AJJ, Shand DG: Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979;26:181-186.
10. Izzo JL, Jr: Hypertension in the elderly: A pathophysiologic approach to therapy. J Am Geriatr Soc 1982;30:352-359.
11. Kalia M, Sullivan JM: Brainstem projections of sensory and motor components of the vagus nerve in the rat. J Comp Neurol 1982;211:248-264.
12. Izzo JL, Jr, Sander E, Larrabee PS, et al: Baroreflex control of postural sympathetic nervous activation (abstract). Proceedings of the High Blood Pressure Research Council, AHA, 1988.
13. + pump. Am J Physiol 1984; 247:H833-H839.
14. Cowley AW, Monos E, Guyton AC: Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial pressure in the dog. Circ Res 1974;34:505.
15. Gribbin B„ Pickering TG, Sleight P, et al: Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 1971;29:424-430.
16. Esler M, Julius S, Zweifler A, et al: Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med 1977;296:405-411.
17. Weidmann P, Beretta-Piccoli C, Ziegler WH, et al: Age vs urinary sodium for judging renin, aldosterone, and catecholamine levels. Kidney Int 1978;14:619.
18. Izzo JL, Jr, Smith RJ, Larrabee PS, et al: Plasma norepinephrine and age as determinants of systemic hemodynamics in men with established essential hypertension. Hypertension 1987;9:415-419.
19. Lake CR, Ziegler MG, Coleman MD, et al: Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. N Engl J Med 1977;296:208-209.
20. Severs WB, Daniels-Severs AE: Effects of angiotensin on the central nervous system. Pharmacol Rev 1973;25:415-449.
21. Izzo JL, Jr, Licht MR, Smith RJ, et al: Chronic effects of direct vasodilation (pinacidil), alpha-adrenergic blockade (prazosin) and angiotensin-converting enzyme inhibition (captopril). Am J Cardiol 1987;60:303-308.
22. Langer SZ: Pre-synaptic regulation of the release of catecholamines. Pharmacol Rev 1980;32:337-362.
23. Hall JE, Guyton AC, Smith MJ, Jr, et al: Long-term regulation of arterial pressure, glomerular filtration and renal sodium reabsorption by angiotensin II in dogs. Clin Sci 1980;59:87S-90S.
24. Messerli FH: Pathophysiologic clinical clues in essential hypertension: A rationale for initial therapy. J Cardiovasc Pharm 1984;6:S528-S534.
25. Goldstein DS: Plasma catecholamines in essential hypertension: An analytical review. Hypertension 1983;5:86-99.
26. Kallay MC, Smith RJ, Izzo JL, Jr: The contribution of plasma norepinephrine, renin and age to compliance (abstract). Chest 1986;89:495.
27. Thomas JA, Marks BH: Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978;41:233-243.
28. Cohn JN, Levine TB, Olivari MT, et al: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-823.
29. Nakada T, Lovenberg W: Lysine incorporation in vessels of spontaneously hypertensive rats: Effect of adrenergic drugs. Eur J Pharmacol 1978;48:87-96.
30. Scott TM, Galway G: The relationship between altered blood vessel structure, hypertension, and the sympathetic nervous system. Can J Physiol Pharmacol 1985;63:387-391.
31. Clayton S, Cross MJ: The aggregation of blood platelets by catecholamines and by thrombin. J Physiol (London) 1963;169:81.
32. Muller JE, Stone PH, Turi ZG, et al: Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-1322.
33. Tofler GH, Brezinski D, Schafer AI, et al: Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987;316:1514-1518.
34. Zweifler AJ, Julius S: Increased platelet catecholamine content in pheochromocytoma: A diagnostic test in patients with elevated plasma catecholamines. N Engl J Med 1982;306:890-894.
35. Born GVR, Smith JB: Uptake, metabolism and release of (3H) adrenaline by human platelets. Br J Pharmacol 1970;39:765-778.
36. Sloand JA, Hooper M, Izzo JL, Jr: Effects of circulating norepinephrine on platelets, leukocyte, and RBC counts by alpha-1 adrenergic stimulation. Am J Cardiol 1989;63:1140-1142.
37. Kontos HA, Wei EP, Navari RM, et al: Response of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol 1978;234:371-383.
38. Heistad DD, Marcus ML, Gross PM: Effects of sympathetic nerves on cerebral vessels in dog, cat, and monkey. Am J Physiol 1978;235:H544-H552.
39. Sadoshima S, Thames M, Heistad DD: Cerebral blood flow during elevation of intracranial pressure: Role of sympathetic nerves. Am J Physiol 1981;241:78-84.
40. McKenzie ET, McCulloch J, O'Keane M, et al: Cerebral circulation and norepinephrine: Relevance of the blood-brain barrier. Am J Physiol 1976;231:483-488.
41. Sadoshima S, Busjia D, Brody M, et al: Sympathetic nerves protect against stroke in stroke-prone hypertensive rats: a preliminary report. Hypertension 1981; 3:124-127.
42. DiBona GF: The functions of the renal nerves. Rev Physiol Biochem Pharmacol 1982;94:75-181.
43. DiBona GF: Neural control of renal tubular sodium reabsorption in the dog. Fed Proc 1978;37:1214-1217.
44. Sullivan JM, Prewitt RL, Josephs JA: Attenuation of the microcirculation in young patients with high-output borderline hypertension. Hypertension 1983;5:844-851.
45. Sen S: Regression of cardiac hypertrophy. Experimental animal model. Am J Med 1983;75:87-93.
46. Izzo JL, Jr, Horwitz D, Keiser HR: Physiologic mechanisms opposing the hemodynamic effects of prazosin. Clin Pharmacol Ther 1981;29:7-11.
47. Lake CR, Ziegler MG: Effect of acute volume alterations on norepinephrine and dopamine-beta-hydroxylase in normotensive and hypertensive subjects. Circulation 1978;57:774-778.
48. Vlachakis ND, Aledort L: Hypertension and propranolol therapy: effect on blood pressure, plasma catecholamines and platelet aggregation. Am J Cardiol 1980;45:321-325.
49. Wikstrand J, Warnold I, Olsson G, et al: Primary prevention with metoprolol in patients with hypertension: mortality results from the MAPHY study. JAMA 1988;259:1976-1982.
50. Cody RJ, Kubo SH, Ryman KS, et al: Systemic and pulmonary hemodynamic responses to nicardipine during graded ergometric exercise in patients with moderate to severe essential hypertension. J Am Coll Cardiol 1987;10:647-654.
51. Izzo JL, Jr, Santarosa RP, Larrabee PS, et al: Increased plasma norepinephrine and sympathetic nervous system activity in essential hypertensive and uremic humans. J Cardiovasc Pharmacol 1987;10:S225-S229.
52. Goldstein DS, Levinson PD, Zimlichman RP, et al: Clonidine suppression testing in essential hypertension. Ann Intern Med 1985;102:42-48.